The objective of this study was to review the available information on the signaling proteins produced by adipose tissue in the context of their role in regulating reproductive processes, including ovarian and uterine function. It is well known that both obesity and excessive leanness are associated with reproductive dysfunction. Adipokines are cytokines predominately or exclusively expressed by adipose tissue that circulate and affect target tissues. Four known adipokines, adiponectin, visfatin/ PBEF, omentin and vaspin, all increase tissue sensitivity to insulin, and are thus described as 'beneficial'. There is strong support for a role for adiponectin in the function of the ovary and placenta. There is evidence for direct effects of this adipokine on the late stages of folliculogenesis, and additive interactions of adiponectin with insulin and gonadotropins in inducing periovulatory changes in ovarian follicles. In addition, clinical and genomic studies associate hypoadiponectinemia with obesity-related reproductive disorders, including the polycystic ovarian syndrome. The roles for visfatin/PBEF, omentin and vaspin in reproduction remain to be established. The conclusion thus drawn is that the expression of insulin-sensitizing adipokines varies with adipose abundance. These adipokines have demonstrated both the potential effects on ovarian function and the possible effects on the formation of the placenta, acting through multiple mechanisms.
Introduction
An intensive investigation of glucose and lipid metabolism and of adipose tissue dynamics in recent years has increased our understanding of the complexities of interactions between food intake and storage. Fat was long known as a depot for triglycerides during times of metabolic affluence, for mobilization during periods of nutrient deprivation. Over the last decade, adipose tissue has emerged as a key element in nutritional regulation, functioning as an endocrine gland to modulate events, including appetite, lipid uptake and metabolism, and even the synthesis of its own constitutive cells. It is known that both the excess of adipose tissue in obesity and its paucity in anorexia result in reproductive dysfunction. In women, obesity correlates with menstrual disorders and infertility, gestational failure and obstetric complications, whereas excessive leanness is associated with amenorrhea, poor fetal growth and miscarriage. Thus, adipose tissue is emerging as an important factor in the complex equation by which the nutritional state regulates reproductive function. One reproductive disorder that is frequently associated with obesity is the polycystic ovarian syndrome (PCOS). About 50% of women diagnosed with PCOS are overweight, and the accretion of adipose tissue often precedes the characteristic ovarian pathology of amenorrhea and anovulation. 1 In fact, PCOS is often first identified because of the symptom of infertility. In reality, it is a larger phenomenon that is often associated with a cluster of disorders known as the metabolic syndrome, including insulin resistance, susceptibility to type II diabetes mellitus, dyslipidemia, hypertension, impaired glucose metabolism and vascular abnormalities. 2 PCOS displays multiple phenotypes, but no single underlying cause for the condition has been identified. 3 Fat secretes hormones known as adipokines, reflecting their origin in adipose tissue and their effects as cytokines on target tissues (Table 1) . Although many of these proteins are primarily expressed by adipose tissue, sensitive techniques for detection have revealed other sites of synthesis and thus presumed paracrine effects for nearly all so far defined. Among the best examples of an adipokine is leptin. Although being produced most abundantly by differentiated adipocytes, leptin can be found in tissues as diverse as digestive epithelium and trophoblast. 16 It has pleiotropic effects on the reproductive process in mammals, acting to stimulate gonadotropin secretion at the hypothalamic and pituitary levels, to directly modulate ovarian steroidogenesis, 17 embryogenesis 18 and in the process of implantation and placental function. 4 The role of leptin in reproduction has been the subject of numerous review articles since its discovery and thus will not be treated in this paper. The reader is referred to the syntheses described in recent literature [4] [5] [6] [7] for further information on this topic.
Among the list of known adipokines (Table 1) , there are at least four that mimic or interact with insulin in the tissues in which they have been studied. One of these is adiponectin, a 30-kDa protein that is the most abundant product of adipose tissue. 10 Its secretion is inversely related to the mass of adipose tissue, 19 and its circulating concentrations become more abundant with dietary restriction and weight loss. 20 Much less is known about the remaining three potentially beneficial adipokines. A screen for differential expression between subcutaneous and visceral fat revealed a second adipokine with insulin mimetic effects, named visfatin. 21 It is a 52-kDa protein preferentially secreted by visceral adipose tissue, and proved to be a identical to a protein known as pre-B-cell enhancing factor (PBEF); thus, it is often referred to as visfatin/PBEF. 22 Its expression is upregulated in obesity.
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Among its effects is the capacity to mimic insulin in lowering blood glucose, acting through the insulin receptor via a novel and poorly understood intracellular pathway. 22 Gene discovery studies of human omental fat yielded a third beneficial factor, a fat-depot-specific protein expressed by the stromal cells of adipose tissue, given the name omentin. 23 Also known as intelectin, it has a predicted molecular weight of 33 kDa and its expression correlates inversely with adiposity. While it can activate intracellular pathways on its own, it also appears to enhance insulininduced glucose uptake in adipocytes. 23 Visceral adipose tissue-derived serpin (vaspin) is a conserved protein of 45 kDa whose expression appears to be confined to adipocytes. 13 It is a secreted protein whose expression correlates with adipose abundance. It is considered beneficial because it enhances insulin induction of glucose uptake. 13 Given that insulin serves as a co-gonadotropin in target tissues, 24 and the frequency of association of obesity, insulin resistance and infertility, 2 these four adipokines are expected to support successful reproduction and can thus be designated the 'beneficial' adipokines. The purpose of this review is to explore their known and potential regulation of female reproduction and fertility, with emphasis on the mechanisms by which this regulation is achieved.
Adiponectin: structure and function
Adiponectin was independently identified by four research groups and thus goes by a series of names, including Acrp30, AdipoQ, GBP28 and apM1. 25 Its structural characteristics include a collagen domain, a globular domain and a crystal structure that resembles members of the tumor necrosis factor family. 25 As with other collagen-domain proteins, the basic form is a trimer, and trimers associate into higher order hexamers and multimers, resulting in the expression and circulation of several forms, including multimeric highmolecular-weight species. 26 Three putative receptors have been identified on the basis of their capability to bind adiponectin, adiponectin receptors 1 and 2 (AdipoR1 and AdipoR2) and the T-cadherin receptor. 27 Full-length adiponectin binds to AdipoR2, whereas the globular domain of adiponectin is believed to preferentially bind the AdipoR1 receptor isoform. 27 These receptors are biologically active, as they bind to a protein known as adaptor protein-containing pleckstrin homology domain, phosphotyrosine-binding domain and leucine zipper motif (APPL1), and provoke intracellular signaling. 28, 29 Circulating adiponectin concentrations correlate negatively with body fat in mammals. 30 The concentration of adiponectin in circulation can exceed 10 mg ml À1 in humans and is inversely related to adipose mass. 26 Fat depot appears Adipokines in reproduction DB Campos et al to be of significance, as there is a greater negative correlation between circulating adiponectin and visceral adipose abundance than with subcutaneous or total fat. 31 Further, women display higher circulating levels than men, and weight loss in both is characterized by increases in adiponectin in plasma. 32 Whereas circulating concentrations of leptin display diurnal pulses and postprandial elevations, adiponectin does not display significant diurnal variation, 33 suggesting that it is not acutely regulated.
In vivo and in vitro investigations have revealed that adiponectin exerts a panoply of effects on target tissues, with the best studied effects being sensitization to insulin, 25 and anti-atherosclerotic 25 and anti-inflammatory effects. 9 The cellular source of recombinant adiponectin defines its structure, as bacterial platforms are incapable of synthesizing the hexamer and consequent association of these oligomers into high-molecular-weight forms. 26 The structure, in turn, determines the activity of adiponectin, as the multimeric form is highly active in liver 10 and endothelial cells, 34 whereas trimeric and full-length monomeric forms provoke responses in a range of tissues. 27 Globular adiponectin, a proteolytic product devoid of the collagen domain, has similar effects to full-length adiponectin in some cellular contexts, best shown by studies of tumor cell lines. 35 In cardiac muscle from newborn rabbits, the globular form regulates fatty acid oxidation, whereas the full-length form has no effect.
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Adiponectin and the metabolic syndrome
The condition known as metabolic syndrome is associated with increased cardiovascular risk and is based on a cluster of symptoms that includes obesity, hyperinsulinemia, insulin resistance, atherogenic dislipidemia and elevated blood pressure. 37 Each of these symptoms also correlates with hypoadiponectinemia, as this adipokine is reduced in abdominal obesity and in conditions coexisting with chronic insulin resistance, atherosclerosis and hypertension. 31 While correlation does not demonstrate causation, the studies on mice bearing null mutations for the adiponectin gene indicate that ablation of this adipokine does, in fact, affect insulin resistance. 38 Reversal of metabolic syndrome symptoms in these mice can be achieved by ectopic expression of adiponectin. These observations led Matsuzawa 31 to conclude that adiponectin deficiency, due to either fat accretion or genetic variation, is a principal factor in the development of the metabolic syndrome. As discussed in detail below, the metabolic syndrome and hypoadiponectinemia are strongly associated with the occurrence of PCOS, suggesting that deficiency in this adipokine plays a role in this ovarian disorder.
Effects of adiponectin on reproduction and fertility
Lord et al., 39 using the pig model, first demonstrated that the mammalian ovary and, in particular, the ovarian follicle, expresses both AdipoR1 and AdipoR2. This finding has been confirmed in rat 40 and human ovaries (DB Campos and BD Murphy, unpublished observations). Treatment of rats with gonadotropins to induce follicular development and ovulation increased the expression of AdipoR1 but not the R2 counterpart. 40 Adiponectin does not appear to regulate its own receptor in ovarian granulosa cells. 41 The isoforms of adiponectin (trimer, hexamer and high molecular weight) are present in both porcine 41 and human follicular fluid 42 at concentrations equivalent to those found in serum. Recent studies in the rat 40 and chicken 43 indicate local production of adiponectin in theca, granulosa and luteal cells of the ovary.
In vitro studies have shown that physiologically relevant levels of recombinant adiponectin induce ovarian gene expression and steroidogenesis in mammalian ovaries, independent of its origin (mammalian vs bacterial). Treatment of pig granulosa cells in vitro with recombinant adiponectin induces the expression of a cluster of proteins associated with the process of ovulation, including cyclooxygenase-2, prostaglandin E2 and vascular endothelial growth factor. 41 In the rat ovary, the synthesis of the steroid hormones, progesterone and estrogen is upregulated by adiponectin. 40 In both studies, responses to adiponectin were additive to gonadotropins, and Ledoux et al. 41 further demonstrated an interaction with insulin. Similarly, in the rat, adiponectin synergized with insulin-like growth factor-1 to induce steroidogenic gene expression and steroidogenesis. 40 Thus, while it is important to note that adiponectin can directly induce ovarian gene expression, the interactions between adiponectin and insulin or insulin-like growth factor-1 are consistent with the role of adiponectin in other tissues, that is, the sensitization to insulin. In support of a role for adiponectin in human folliculogenesis and ovulation, circulating adiponectin positively correlates with the number of oocytes retrieved in women treated with follicle-stimulating hormone (FSH) to induce superovulation for the purpose of in vitro fertilization. 44 Evidence for the effects of adiponectin on the human ovary is also derived from the observation of reduced adiponectin levels in women diagnosed with PCOS, independent of obesity. [45] [46] [47] Recent findings indicate that adiponectin may also be active in the uterus and placenta. Both AdipoR1 and R2 are highly expressed in the endometrium of the pig. 39 In the human endometrium, AdipoR1 and R2 are present in the endometrial and glandular epithelium, as well as in the stromal fibroblasts. 54 Transcript and protein abundance for both receptors was highest during the secretory or progestational phase of the menstrual cycle. 54 Investigations in the placenta demonstrate that both receptors are present in the human and rat placentae. 55 In studies of AdipoR2 during gestation, it was reported that human cytotrophoblast and syncytiotrophoblast, as well as endometrial stroma, expressed this form of the receptor. Studies have further shown that the trophoblast and placenta are local sources of adiponectin expression. 55, 56 In vitro tissue explant studies of human term placenta indicate that adiponectin can be secreted 57 and that it upregulates placental cytokine release. 58 Together, these studies strongly suggest paracrine effects of adiponectin in placental function. Local or peripheral adiponectin may influence the formation of the placenta. The unpreventable human condition of pre-eclampsia is a placental disorder characterized, in the late stages of gestation, by maternal hypertension and proteinuria. It results from inadequate placental formation, in particular from inadequate vascular invasion following embryo implantation. 59 Obesity is a risk factor in preeclampsia, 59 as is the metabolic syndrome. 60 More pertinent to this discussion, there is genomic evidence that the condition is associated with one of the same polymorphisms of the adiponectin gene, SNP276, that correlates with ovarian disorders. 61 The few studies showing that circulating profiles of adiponectin vary through human gestation are contradictory. Fuglsang et al. 62 demonstrated variation, with peak values at mid-pregnancy, whereas Suwaki et al. 63 reported no differences during human gestation. Studies on rats support the latter view of no specific pattern in circulating adiponectin during pregnancy. 64 There is nonetheless strong evidence for the association of circulating hypoadiponectinemia during the first trimester with preeclampsia, compared with levels found in normal pregnancies. 65 This pattern is reversed in late pregnancy, as pre-eclampsia is associated with hyperadiponectinemia. 66 Other studies report that hypoadiponectinemia and preeclampsia correlate only when obesity 63 and gestational diabetes 67 are present as complicating factors.
Mechanisms of action of adiponectin in reproductive tissues
As can be seen above, there is abundant evidence, both direct and correlative, to suggest that adiponectin has beneficial effects on reproductive processes. The pleiotropic nature of adiponectin across the spectrum of tissues where it interacts suggests that it employs multiple intracellular signal transduction pathways. Further, more than one pathway may subserve adiponectin induction of a cellular response, and adiponectin interacts with other hormones, in particular with insulin and insulin-like growth factors. In ovarian granulosa cells, adiponectin and insulin have additive effects in the induction of expression of target genes, 41 while insulin-like growth factor-1 substantially enhanced the response to adiponectin. 40 There is also evidence for additive interaction between adiponectin and luteinizing hormone in pig granulosa cells. 41 The most common and perhaps canonical route by which adiponectin acts on target tissues is via the AMP-activated protein kinase pathway. 27 This is the best known mechanism by which the multimeric forms of adiponectin induce glucose uptake and lipid oxidation. 10 In human aortic endothelial cells, the cyclic AMP or protein kinase A pathway was evoked by adiponectin, 68, 69 whereas in other endothelial cell models, the phosphoinositol kinase 3/protein kinase B (PKB) or Akt system transduces the adiponectin signal. 34 There is evidence for adiponectin activation of the peripheral peroxisome-activated receptor-g in placental tissue 57 and mitogen-activated protein kinase pathways in vascular tissue 70, 71 and osteoblasts. 72 The recent discovery of interactions between the AdipoR1 and R2 and the adapter protein APPL1 28, 29 has provided new insight into the mechanism by which adiponectin can act on target tissues. APPL1 has been implicated in the regulation of cross-talk between the insulin and adiponectin transduction pathways. 28 In addition, the interaction of APPL1 with epidermal growth factor induces translocation of the linker protein to the nucleus, where it associates with a chromatin-remodeling complex that regulates transcription. 73 It is reasonable that interactions of APPL1 with adiponectin, FSH and insulin receptors may precipitate a similar signaling process, although no data yet exist to confirm this assumption. Figure 1 depicts the known and assumed pathways for the transduction of the adiponectin signal in ovarian granulosa cells. Reports of the direct effects of adiponectin on the ovary showed that adiponectin induces the phosphorylation of AMP-activated protein kinase in porcine 41 and rat granulosa cells. 40 Nonetheless, the potent AMP-activated protein kinase agonist, 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside, does not recapitulate the effects of adiponectin on the granulosa cell expression of cyclooxygenase-2, 41 suggesting that this pathway may not be relevant to the ovarian actions of adiponectin. Studies have further implicated that the mitogen-activated protein kinase pathway, in particular the phosphorylation of extracellular signalregulated kinases 1 and 2, is induced by adiponectin in granulosa cells. 40, 41 A specific antagonist of extracellular signal-regulated kinase 1/2 phosphorylation blocks adiponectin induction of cyclooxygenase-2 expression. 41 The role of APPL1 has not yet been explored, although there is intriguing new information to demonstrate interaction Adipokines in reproduction DB Campos et al between the FSH receptor, a protein found only in the granulosa cell in female mammals, and APPL1. 74 The sequelae of this interaction are not yet known, but may be part of the mechanism by which FSH activates the Akt/PKB pathway. 75 Indeed, in rat granulosa cells, adiponectin provokes phosphorylation of Akt/PKB, 40 and in other tissues Evidence indicates that FSH can also interact with APPL1, presumably via the C-terminal intracellular domain, with the potential, and it is further known that FSH via unknown intermediates, induces phosphoinosital-3 kinase activation and thus the Akt or protein kinase B pathway. Insulin likewise functions through this mechanism, although direct interaction between the insulin receptor and APPL1 has not been shown. Translocation of APPL1 to the nucleus, and consequent interaction with chromatin-remodeling complexes to influence transcription, represents a further potential pathway for signal transduction by adiponectin. AdipoR1, adiponectin receptor 1; AdipoR2, adiponectin receptor 2; FSH, follicle-stimulating hormone.
Adipokines in reproduction DB Campos et al the Akt/PKB enzyme system is activated by insulin. 76 In the context of interaction with insulin, small interfering RNA (siRNA) knockdown of APPL1 expression interferes with insulin induction of Akt/PKB in muscle cells. 28 Although direct confirmation is lacking, it may be that APPL1 interacts directly with the insulin receptor. Further clarification is required, with emphasis on the understanding of hormone/ adiponectin interactions in the ovary. The state of information on adiponectin signaling in the uterus/placenta provides a similar, if equally incomplete, picture. Adiponectin and 5-aminoimidazole-4-carboxamide-1-b-D-ribofuranoside induce AMP-activated protein kinase phosphorylation in human epithelial and stromal endometrial cells. 54 In explants of human term placenta, interference with the phosphorylation of extracellular signal-regulated kinase 1/2 inhibited adiponectin induction of a number of target genes, including the inflammatory cytokines interleukin-1 and interleukin-6, 58 confirming a role for this pathway in transduction of the signal in the placenta.
Does adiponectin play an essential role in ovarian/ uterine/placental function?
The above evidence, primarily from genomic and in vitro studies, strongly implicates adiponectin in regulation of the function of the ovary, uterus and placenta, but does not provide definitive evidence that it is essential to female reproduction. Mouse gene deletion and overexpression models support a role for the adipokine in fertility, albeit not unambiguously. Two models of inactivation of the adiponectin gene have been developed. In the first model there was replacement of exon 2, the region that contains the transcription initiation site, 38 whereas in the second, all three coding exons and the 5 0 untranslated region were deleted. 76 In both models, manifestation of the characteristics of adiponectin deficiency, including insulin resistance, occurred and was more pronounced following feeding a high-fat diet 38 or glucose loading. 76 In male mice homozygous for the AdipoR2 deletion, diet-induced insulin resistance was surprisingly diminished. 44 All three lines were bred as heterozygotes from the F0, and there are no reports of reduced fertility, although it would appear that extensive trials have not been carried out. The fact that offspring genotypes occurred at expected Mendelian ratios following heterozygote matings 76 suggests that embryogenesis and the embryonic component of the placenta were not compromised by the absence of the adiponectin gene. In contrast, in a model of targeted modification of the adiponectin gene with the unintended phenotype of reduced expression of adiponectin by adipose tissue, the majority of the founders (gender unspecified) were infertile, whereas others were subfertile. 77 Another, quite remarkable finding, was that deletion of a portion of the collagen domain of adiponectin increased the rate of secretion of a modified form, but resulted in infertility in female but not male mice. 78 New studies of null mutation of AdipR1 and R2 indicate that both offspring and their crosses (knockout of both receptors) are capable of successfully breeding, but it would appear that extensive breeding trials have not been conducted. Given these ambiguities, it is not possible to conclude whether the role of adiponectin in reproduction is facultative or obligatory.
In spite of the pleiotropic and widespread effects of adiponectin, it may be that its major effect on ovarian function and fertility is related to its role in increasing sensitivity to insulin. Indeed, short-term treatment with metformin, a biguanide that increases peripheral sensitivity to insulin, dramatically improves both spontaneous and clomiphene-assisted ovulatory rates in PCOS patients. 79 Longer term treatment restored menstrual cycles in some anovulatory PCOS patients and reduced circulating androgens. 80 Nonetheless, in the sole mouse model in which female infertility is documented and in which the collagen domain of adiponectin is partially deleted, insulin sensitivity is increased. 78 Further, in vitro investigations have demonstrated additive interactions between gonadotropic hormones and adiponectin, an effect that was independent of insulin. 41 Thus, it appears that insulin sensitivity is not the only mechanism of adiponectin action in reproductive tissues.
The other beneficial adipokines visfatin/PBEF, omentin and vaspin
Visfatin/PBEF was first identified and shown to be expressed in liver, bone marrow and muscle. 81 It was later described as a factor preferentially secreted by visceral adipose tissue. 21 More recent studies have indicated that it is more widely expressed, 82 and includes constitutive expression in human trophoblast and fetal membranes. 83, 84 The most striking of the visfatin/PBEF effects is its capacity to mimic insulin in lowering blood glucose, acting through the insulin receptor, via a novel and poorly understood intracellular pathway. 21 A recent study indicated that visfatin/PBEF was elevated in the circulation of type-2 diabetes patients. 85 Increased visceral expression of visfatin/PBEF with parallel increase in circulating concentrations is associated with the occurrence of PCOS. 86 In contrast, the measurement of visfatin/PBEF in women with gestational diabetes indicated that this condition was characterized by lower circulating concentrations of the factor. 87 A genomic investigation revealed that variants in promoter sequence correlate with type-2 diabetes but not with measures of adiposity, 88 whereas a second study indicated significant association of promoter variants with fasting insulin. 89 The identification of visfatin/PBEF as an adipokine and its implication in diabetes is far from being universally accepted. 22, 82 In particular, it has been noted that the 91 It has been described as being predominately expressed in visceral adipose tissue, but it is also found in the human lung, intestine and heart. 23 It is strongly expressed in the human ovaries and placenta. 92, 8 It is a secreted protein, with the most profound level of expression in the stromal cells, rather than the adipocytes, of omental adipose tissue. 23 Recombinant omentin enhances the uptake of glucose in isolated adipocytes and dramatically increases the insulin induction of Akt/PKB phosphorylation. 23 No studies have yet emerged to address the relation between omentin and obesity, insulin resistance or fertility.
There is but a single report of the occurrence of vaspin. 13 It demonstrates the specificity of the protein to adipocytes and suggests that it is present in both subcutaneous and visceral fat depots and circulates in serum. In rodent models, expression increases with fat accretion. In vivo trials on a strain of mice that displayed hyperglycemia, hyperinsulinemia and obesity when fed a high-fat diet demonstrated that vaspin increased insulin-induced glucose uptake. While the mechanism is not known, there is speculation that vaspin serves as a serpin protease inhibitor to antagonize proteases that inhibit insulin action. To date, no gene deletion or other studies have been published, and there is no information on the potential relevance to adipose modulation of reproduction and fertility.
Perspectives
Recent investigations have yielded new information on the endocrine role of adipose tissue via the expression protein messengers known as adipokines. Their secretion is related to the abundance of the adipose tissue and is regulated by autocrine and endocrine factors, predominately by gonadal steroids. At least four of these have been shown to enhance the sensitivity of peripheral tissues to insulin. A unified view of their significance in adipose-related reproductive disorders is complicated by the fact that expression of some (visfatin/PBEF, vaspin) correlates directly with adipose abundance, whereas with adiponectin and omentin the relation is inverse. The best studied of these, adiponectin, displays measurable effects on the events of late folliculogenesis and ovulation. Its occurrence in the uterine and placental tissues argues for its function in the establishment and maintenance of gestation. A case can be made that adiponectin is an important regulator of reproductive events and that its reduction in obesity causes reproductive dysfunction in humans. The importance of the other beneficial adipokines in the spectrum of reproductive events remains unexplored.
